FDA panel backs previously rejected obesity pill – USA TOMORROW
USA TODAY
FDA panel backs previously rejected obesity pill
USA TOMORROW
A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill called Qnexa, a drug which the FDA previously rejected due to safety concerns. Paul Sakuma, AP Qnexa is a combination of …
Advisory Panel Favors Approval for Weight-Loss Drug
US advisers back experimental obesity pill
all 320 news articles »
Related posts:
- US to Review Diet Treatment Once Rejected – New York Times
- Insomnia drug for middle of the night wakers approved by FDA – USA Tomorrow
- Bayer Birth Control Pill Benefits Outweigh Risks, Panel Says – BusinessWeek
- Side Effects Of Diet Pill Still Concern Regulators – Fresh York Times
- FDA is wary of diet pill’s safety – Bend Bulletin
Categorised as: hot babe